Alkeran

Active Ingredient(s): Melphalan
FDA Approved: * January 17, 1964
Pharm Company: * GLAXOSMITHKLINE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Alkeran Overview

Melphalan (trade name Alkeran, in former USSR also known as Sarcolysin) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents. An alkylating agent adds an alkyl group (CnH2n+1) to DNA. It attaches the alkyl group to the guanine base of DNA, at the number 7 nitrogen atom of the imidazole ring. Otherwise known as L-phenylalanine mustard, or L-PAM, melphalan is a phenylalanine derivative of chlormethine. Contents 1 Mechanism of action 2 Uses 3 Administration 4 S...

Read more Alkeran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Melphalan

Recent Alkeran Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Melphalan
  • Injection: 50mg, 50mg/vial
  • Powder: 50mg/vial
  • Tablet: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Alkeran: (3 results)

Sorted by National Drug Code
  • 52609-0001 Alkeran 2 mg Oral Tablet by Apo-pharma USA, Inc
  • 52609-3001 Alkeran Kit by Apo-pharma USA, Inc
  • 63379-018 Alkeran Kit by Glaxo Operations Uk Ltd

Other drugs which contain Melphalan or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA